HHS Secretary Robert F. Kennedy Jr. has claimed without scientific basis that SSRIs are as addictive as heroin and linked ...

Sooma announced that it received FDA investigational device exemption (IDE) for its transcranial direct current stimulation ...

Genetic testing is transforming depression treatment by tailoring antidepressants to your DNA for better results and fewer side effects.

A new study has found that adults with depression who start treatment with newer antipsychotic medications may face a higher ...

It's marketed as a generic option to name-brand mood meds, but it's been recalled for the same reason a competitor was just ...

Analysts say the decision is a “big blow” to a once-promising class of brain therapies that include’s J&J’s aticaprant and a ...

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...

Legislation requiring healthcare professionals assess a woman for postpartum depression made it over the first hurdles last ...

This summary highlights key global health developments, including J&J halting studies of a depression drug due to low ...

Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

Sooma Medical has received the approval of an investigational device exemption (IDE) from the US Food and Drug Administration ...

Johnson & Johnson discontinues aticaprant's Phase 3 trial but explores future options. Another depression drug Spravato sales hit $1.01 billion ...